05.07.2021
Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID 19 Vaccine
05.06.2021
Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games
05.04.2021
PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS
04.28.2021
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
04.28.2021
Pfizer Acquires Amplyx Pharmaceuticals
04.22.2021
Pfizer Declares Second-Quarter 2021 Dividend
04.19.2021
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
04.15.2021
Pfizer Invites Shareholders to Attend Virtual-Only 2021 Annual Meeting of Shareholders on April 22
04.12.2021
Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet
04.07.2021
Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis
view all press releases & statements
media
Media
Contacts

Get to Know Us

Company Fact Sheet
Featured Stories
Podcasts
Press Kits
@Pfizer
@Pfizer_News